Purchase Short-Term Access
Review: Interferon and nucleoside/tide analogues reduce risk for hepatocellular cancer in patients with chronic hepatitis B
Averell H. Sherker, MD, FRCP(C)
Annals of Internal Medicine 2009;150:JC4-11.
doi:10.7326/0003-4819-150-8-200904210-02011
Purchase Online access to this article for 24 hours
